WoodTrust Financial Corp Acquires 735 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

WoodTrust Financial Corp raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,411 shares of the healthcare conglomerate’s stock after buying an additional 735 shares during the quarter. UnitedHealth Group comprises 1.9% of WoodTrust Financial Corp’s portfolio, making the stock its 16th biggest holding. WoodTrust Financial Corp’s holdings in UnitedHealth Group were worth $13,103,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in UNH. China Universal Asset Management Co. Ltd. grew its holdings in UnitedHealth Group by 20.6% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after buying an additional 1,857 shares in the last quarter. Quent Capital LLC boosted its holdings in shares of UnitedHealth Group by 5.5% in the 1st quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after purchasing an additional 217 shares during the period. MGB Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 0.7% in the 1st quarter. MGB Wealth Management LLC now owns 3,937 shares of the healthcare conglomerate’s stock worth $1,947,000 after purchasing an additional 29 shares during the period. Concord Investment Counsel Inc. purchased a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $14,544,000. Finally, Duality Advisers LP purchased a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $4,602,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 5.2 %

Shares of NYSE UNH opened at $596.69 on Thursday. The business has a fifty day moving average price of $581.13 and a 200 day moving average price of $543.74. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The stock has a market capitalization of $551.00 billion, a P/E ratio of 38.87, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the business posted $6.56 earnings per share. The firm’s revenue was up 9.2% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Analyst Upgrades and Downgrades

UNH has been the topic of several research analyst reports. Wells Fargo & Company upped their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Robert W. Baird upped their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. KeyCorp initiated coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. UBS Group cut their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, Barclays lowered their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.